Leading pharmaceutical companies in China use the Medidata cloud platform and mobile medical technology to collect objective data
(New York, Shanghai) - September 7, 2016 – Medidata (NASDAQ: MDSO) , the world's leading provider of cloud solutions for life sciences , announced today that China's pharmaceutical company Suzhou Techfields Pharmaceutical Co., Ltd. (hereinafter referred to as "Techfields") has selected Medidata Clinical Cloud ® platform to help a phase II study of ischemic stroke. Techfields will leverage Medidata's strong research management capabilities and mobile medical technology to optimize the testing process and gain up-to-date insights into treatment efficacy and patient quality of life.
Dr. Yu Chongxi, founder and president of Techfields, said: “Cloud platform and mobile medical technology provide a new channel for maximizing the value of clinical data. We believe that these technologies will increasingly influence our ability to bring important new drugs to patients. Using Medidata's cloud platform, our research team is able to access richer, more complete clinical data and learn valuable information about patient health and disease progression. This is in line with our research's core strategy and efforts to help people better. A long-lived and promising drug candidate."
Headquartered in Suzhou, Techfields is a leading clinical stage pharmaceutical company dedicated to the development of innovative drugs, targeting inflammation, autoimmune diseases, cardiovascular diseases, metabolic disorders and aging-related diseases and depression. To streamline trials of upcoming Phase II ischemic stroke studies and improve data quality, Techfields will use Medidata's integrated cloud technology solution for electronic data collection ( Meddata Rave ® ), randomized distribution and trial supply management ( Medidata Balance ® ) and the mobile medical technology ( Medidata Patient Cloud ).
Techfields used Medidata's SensorLink to collect their ongoing data on sports and normal activities from the Garmin vívofit health bracelet worn by the subjects. At the same time, Techfields also uses Medidata's electronic patient report results (ePRO) application, which can be easily downloaded to a smartphone or tablet, allowing the stroke patients participating in the trial to use the iPad to answer questions about their quality of life and disease status. And a questionnaire for treatment response. Data generated by mobile healthcare solutions will be automatically imported into the Medidata Clinical Cloud, a secure, regulatory-compliant cloud platform.
Mr. Huang Guiping, Vice President of Operations, Asia Pacific, Medidata, said: “At this moment, life sciences companies are more focused on patient-centered practices in drug development and healthcare, and Medidata's integrated cloud platform , including our mobile healthcare solutions, can help drive this transformation. We are excited to be a technology partner of Techfields, working with them to collect and analyze large amounts of patient data in an objective and regulatoryly compliant manner. Our team is very excited to see more customers like Techfields to help them develop safer and faster drugs that truly change the lives of patients."
About Suzhou Techfields Pharma Co. Ltd.
Suzhou Techfields Pharma Co. Ltd. is a leading clinical stage pharmaceutical company dedicated to the development of innovative drugs, mainly for inflammation, autoimmune diseases, cardiovascular diseases, metabolic abnormalities, depression and aging-related diseases. The company has successfully produced an innovative transdermal drug delivery system platform that allows drugs to pass through skin, blood and blood cells and other cell membrane barriers at speeds of up to a thousand times, and can achieve hundreds of times more potent drugs than other drugs. The effect - this not only greatly enhances the existing treatment effect, but also treats diseases that were previously incurable. The transmission mechanism can be applied on a large scale, and Techfields expects that most of the drugs will be transmitted through the skin in the future, and this technology will fundamentally change the pharmaceutical industry.
Founded in 2004, Techfields is headquartered in Suzhou and has offices in New Jersey, USA.
About Medidata
Medidata is the world's leading provider of cloud solutions for life sciences clinical research, improving clinical development through its advanced applications and electronic data analysis. We are committed to helping our global customers advance their market competition and scientific research goals. Our clients include: more than 700 global pharmaceutical companies, innovative biotechnology, diagnostic and medical device companies, leading academic medical centers and contract research organizations (CROs). Our industry-leading cloud technology platform, Medidata Clinical Cloud, is the leading technology solution for 17 of the world's top 25 pharmaceutical companies in clinical trials, improving productivity and quality for promising drug therapy clinical trials, enabling research The design, planning and execution, management and reporting have all been improved.
Asia Pacific (excluding Japan) media linking Person:
Danielle (Da Jeong) Chong, Medidata Solutions, 82 2-2015 7715, dchong@mdsol.com
Li Peishan, FTI Consulting, 86 21-2315 1068, ps.lee@fticonsulting.com